Abstract
The Acknowledgements section of this Letter should have included the following sentence: “We acknowledge the contribution of M. A. Jarvis to the design, construction and initial in vitro characterization of all the strain 68.1-derived RhCMV vectors used in this study, including both previously published RhCMV/SIV vectors and a previously unpublished vector expressing an Mycobacterium tuberculosis Ag85B–ESAT6 fusion protein, used as a negative control in this study.” S.L.P. and J.M.T. did not reply when asked to approve the wording of this Corrigendum. The HTML version of the paper has been corrected.
Original language | English |
---|---|
Pages (from-to) | 654-654 |
Number of pages | 1 |
Journal | Nature |
Volume | 514 |
Issue number | 7524 |
DOIs | |
Publication status | Published - 30 Oct 2014 |
Keywords
- vaccines
- live attenuated
- pathogens